ReviewCurrent cardiology reports2017
Ablative Radiotherapy as a Noninvasive Alternative to Catheter Ablation for Cardiac Arrhythmias.
Review in Current cardiology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Stereotactic Radiotherapy Ablation and Atrial Fibrillation: Technical Issues and Clinical Expectations Derived From a Systematic Review.Frontiers in cardiovascular medicine · 2022Pooled it
- Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib/II study.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2021Trial
- A respiratory motion analysis for guiding stereotactic arrhythmia radiotherapy motion management.Medical physics · 2026Article
- A motion analysis of cardiac substructures for guiding stereotactic arrhythmia radiotherapy motion management.Medical physics · 2025Article
- Evaluation of the impact of cardiac implantable electronic devices on cine MRI for real-time adaptive cardiac radioablation on a 1.5 T MR-linac.Medical physics · 2025Article
- Radiation-associated cardiovascular disease in patients with cancer: current insights from a cardio-oncologist.Journal of radiation research · 2024Review
- Analysis of left ventricle regional myocardial motion for cardiac radioablation: Left ventricular motion analysis.Journal of applied clinical medical physics · 2024Article
- Stereotactic arrhythmia radioablation (STAR) opens a new era in the treatment of arrhythmias?Frontiers in cardiovascular medicine · 2024Review
- The state-of-the-art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overview.Health science reports · 2023Article
- Multimodality imaging fusion to guide stereotactic radioablation for refractory complex ventricular tachycardia.HeartRhythm case reports · 2022Article
- Stereotactic Arrhythmia Radioablation as a Novel Treatment Approach for Cardiac Arrhythmias: Facts and Limitations.Biomedicines · 2021Review
- STRA-MI-VT (STereotactic RadioAblation by Multimodal Imaging for Ventricular Tachycardia): rationale and design of an Italian experimental prospective study.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2021Article
- Review of Stereotactic Arrhythmia Radioablation Therapy for Cardiac Tachydysrhythmias.CJC open · 2021Review
- Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA).Clinical research in cardiology : official journal of the German Cardiac Society · 2020Article
- Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.Nature reviews. Cardiology · 2020Review
- Hybrid Catheter-Based and Surgical Techniques for Ablation of Ventricular Arrhythmias.Arrhythmia & electrophysiology review · 2020Review
- Non-invasive Stereotactic Radioablation: A New Option for the Treatment of Ventricular Arrhythmias.Arrhythmia & electrophysiology review · 2020Review
- Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions.Frontiers in cardiovascular medicine · 2020Review
- Case Report: A Case Report of Stereotactic Ventricular Arrhythmia Radioablation (STAR) on Large Cardiac Target Volume by Highly Personalized Inter- and Intra-fractional Image Guidance.Frontiers in cardiovascular medicine · 2020Article
- Biological Cardiac Tissue Effects of High-Energy Heavy Ions - Investigation for Myocardial Ablation.Scientific reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewStereotactic radioablation is a commonly utilized technology to noninvasively treat solid tumors with precision and efficacy. Using a robotic arm mounted delivery system, multiple low-dose ionizing radiation beams are delivered from multiple angles, concentrating ablative energy at the target tissue. Recently, this technology has been evaluated for treatment of cardiac arrhythmias. This review will present the basic underlying principles, proof-of-principle studies, and clinical experience with stereotactic arrhythmia radioablation. RECENT
findingsMost recently, stereotactic radioablation has been used to safely and effectively treat a limited number of patients with malignant arrhythmias, including ventricular tachycardia (VT) and atrial fibrillation (AF). Treatment protocols, outcomes, ongoing studies, and future directions will be discussed. Stereotactic radioablation is a well-established technology that has been shown to be a safe and effective therapy for patients with drug-refractory cardiac arrhythmias, including VT and AF. Further clinical evaluation to define safety and efficacy in larger populations of patients is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.